Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

Curaleaf Holdings Inc. shares CURLF, -1.92% CURA, -1.94% fell 2.1% Tuesday, after a report highlighted difficulties facing the company in the Florida market.

Curaleaf stock hit by analyst note highlighting difficulty in Florida

Shares will be released on a timetable that ends in March 2021.

Top Curaleaf Shareholders Extend Stock Lockup

Curaleaf Holdings, Inc. (CSE: CURA) (OTC: CURLF), a vertically integrated cannabis company, said Monday that shareholders who hold around 75% of the company’s outstanding shares have signed an amended and extended lockup agreement.

'Ongoing Support For The Company': Curaleaf Shareholders Sign Extended Lockup Agreement

Green Thumb Industries Inc.

Forget Canopy Growth and Aurora Cannabis. These should be the true marijuana industry revenue kingpins next year.

3 U.S. Pot Stocks That Can Outsell All Canadian Growers in 2020

Removing illegal pot shops from its site could help drive customers to licensed cannabis operators.

Why Weedmaps Could Play a Big Role in Helping Cannabis Companies Grow

Innovative Industrial Properties

Neptune Wellness Solutions Inc.

The United States is the marijuana industry's crown jewel, but not every company will be a winner.

U.S. Cannabis Sales to More Than Quintuple by 2025, New Report Finds

Canopy Growth

MedMen Enterprises Inc.

A number of marijuana acquisitions are taking longer than expected to close.

Will These U.S. Cannabis Megadeals Ever Be Completed?

Curaleaf Holdings, Inc. (CSE: CURA) (OTC: CURLF) announced Monday that Curaleaf NewYork has launched New York State’s first medical flower products, Curaleaf Ground Flower Pods.

Curaleaf To Offer First Medical Cannabis Flower Products In New York

The former Canopy Growth CEO is getting involved with multiple businesses, including one that's focused on making CBD pet products.

1 Segment of the Cannabis Industry That Bruce Linton Is Bullish On

Curaleaf is on a path to lead the cannabis market in revenues.

Curaleaf: Under The Radar Giant

Studies on cannabidiol and what it can and cannot do have been limited, but that hasn't stopped advertisers from making some very aggressive claims.

More Cannabis Companies Are Getting Warning Letters From the FTC

Three U.S. pot firms are well-positioned to benefit from a growing cannabis market, making their stocks look like bargains compared to Canadian rivals.

3 U.S. Cannabis Stocks With the Most Upside

Cowen analyst Vivien Azer initiated coverage Friday of five multi-state cannabis operators, saying she's bullish on those that rely on the consumer packaged goods model given the higher margins, especially relative to those relying on the retail model.

Cowen is bullish marijuana companies with CPG model, bearish on MedMen given retail reliance

Vertically integrated cannabis company Curaleaf Holdings, Inc. (CSE: CURA) (OTC: CURLF) said Thursday it has become the first company in Florida to provide medical cannabis tablets.

Curaleaf Introduces First Medical Cannabis Tablets In Florida

The company says it is first to market with this form of medication in the state.

Curaleaf Launches Sales of Cannabis Tablets in Florida

North American cannabis sales are set to surpass $47 billion in less than five years, according to Prohibition Partners.

U.S. Marijuana Sales Will Be 12 Times Higher Than Canada by 2024, Report Shows

Three vertically integrated multistate operators look attractive to Canaccord Genuity.

These U.S. Pot Stocks Are a Bargain, According to This 69-Year-Old Investment Bank

Two of these three states should be billion-dollar cannabis markets by 2024.

These 3 States Will Begin Selling Recreational Pot Fairly Soon

The company's latest retail outlet is located in Port Charlotte, Florida.

Curaleaf Opens 49th Dispensary; Stock Rises Almost 8%

The company has some bold predictions for the year ahead that could make investors very rich.

Is Curaleaf a Good Cannabis Stock to Buy Now?

GW Pharmaceuticals

Here's what to expect from a government agency that's listening to what people have to say about marijuana legalization.

Is the U.S. Getting on Board With Cannabis Legalization?

Curaleaf Holdings, Inc. (CURLF) CEO Joe Lusardi on Q2 2019 Results - Earnings Call Transcript

The company's busy acquisition strategy has affected profitability.

Curaleaf Q2 Misses on Revenue, Deepens Net Loss

Curaleaf Holdings Inc (OTC: CURLF), one of the largest verticallyintegrated cannabis operators in the U.S.

Curaleaf's Q2 Revenue Grows 231% Year-Over-Year

The company unloads six properties to a specialty real estate company.

News for Curaleaf Holdings, Inc. Stock (CURLF)